7 completed, 2 active not recruiting, 1 not yet recruiting, 1 unknown. 6 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Active not recruiting 1, Not yet recruiting 1 |
| Not applicable | 2 | Active not recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Relaxin: new trials by email Literature Review of Relaxin trials Research Report on Relaxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relaxin Therapy for Atrial Fibrillation Relaxin, Placebo - Atrial Fibrillation (AF), Arrhythmia | Phase 1 / Phase 2 | Not yet recruiting | Deeptankar DeMazumder | 208 | 2027-01-01 | 2026-01-22 |
| Progressive Relaxation for COPD: Effects on Insomnia and Satisfaction relaxin - COPD, Insomnia | Not applicable | Active not recruiting | Ceylan Aksoy | 70 | 2025-02-01 | 2025-08-24 |
| Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden relaxin, kontrol - Caregiver Burnout, Caregiver | Not applicable | Unknown | Seda KARAKAYA ERGUN | 64 | 2024-11-07 | 2024-11-13 |
| Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in Women With Chronic Pelvic Pain interleukin, enzyme, hormone - Endometriosis | Completed | Sanliurfa Mehmet Akif Inan Education and Research Hospital | 60 | 2022-06-15 | 2024-10-08 | |
| Relaxin and Placental Volume in Placenta Accreta Spectrum relaxin - Placenta Accreta Spectrum, Placenta Accreta / Percreta | Completed | Başakşehir Çam & Sakura City Hospital | 40 | 2022-01-01 | 2026-09-30 | |
| A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin Apelin, Relaxin, Normal saline - Cardiovascular Diseases, Type 2 Diabetes Mellitus | Phase 2 | Active not recruiting | Cambridge University Hospitals NHS Foundation Trust | 170 | 2018-03-28 | 2026-09-30 |
| Study of the Vascular Effects of Serelaxin Serelaxin, Placebo - Coronary Artery Disease | Phase 2 | Completed | Novartis Pharmaceuticals | 58 | 2014-02-03 | 2019-07-01 |
| Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure Relaxin, Placebo - Heart Failure, Congestive | Phase 2 / Phase 3 | Completed | Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | 1161 | 2007-10-01 | 2012-10-30 |
| A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure Relaxin - Heart Failure, Congestive | Phase 2 | Completed | Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | 18 | 2005-11-01 | 2009-04-15 |
| Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma Relaxin - Systemic Sclerosis | Phase 3 | Completed | University of Medicine and Dentistry of New Jersey | 231 | 1998-12-01 | 2008-06-25 |
| Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis relaxin - Systemic Sclerosis | Phase 2 | Completed | National Center for Research Resources (NCRR) | 1 | 1991-12-01 | 2005-06-24 |
Heart Failure (3) · Scleroderma, Systemic (2) · Arrhythmias, Cardiac (1) · Arthritis (1) · Atrial Fibrillation (1) · Cardiovascular Diseases (1) · Caregiver Burden (1) · Connective Tissue Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Endometriosis (1) · Placenta Accreta (1) · Pulmonary Disease, Chronic Obstructive (1) · Rare Diseases (1) · Renal Insufficiency (1)
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies (2) · Başakşehir Çam & Sakura City Hospital (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Ceylan Aksoy (1) · Deeptankar DeMazumder (1) · National Center for Research Resources (NCRR) (1) · Novartis Pharmaceuticals (1) · Sanliurfa Mehmet Akif Inan Education and Research Hospital (1) · Seda KARAKAYA ERGUN (1) · University of Medicine and Dentistry of New Jersey (1)
Turkey (Türkiye) (4) · United Kingdom (2) · Germany (1) · Israel (1) · United States (1)
Deeptankar DeMazumder, MD, PhD (1) · G. Scott Herron (1) · Joseph Cheriyan, MBCHB, FRCP (1) · Sam Teichman, MD (1) · Thomas Severin, MD (1)
PMID 19329178, PMID 21622980, PMID 22305830, PMID 23141816, PMID 23302396, PMID 25287144, PMID 25301463, PMID 27838739, PMID 34514815, PMID 35184572